Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared Holz

May 19, 2023
Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared HolzBlocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho healthcare sector strategist, joins ‘Fast Money’ to discuss merger and acquisition crackdowns in the biotech space, government regulation in the space, and more.

Latest Mizuho News

Mizuho’s Jared Holz on Moderna’s leg up on new cancer shot data

Mizuho’s Jared Holz on Moderna’s leg up on new cancer shot data

August 19, 2026
Nvidia holders to focus on AI data, Mizuho's Rakesh says

Nvidia holders to focus on AI data, Mizuho's Rakesh says

August 26, 2026
Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

August 10, 2026

Mizuho news from around the globe

back-to-top-blue